Mercator Medical (FRA:MM2) Marketable Securities: €11.6 Mil (As of Mar. 2026)


FRA:MM2 Mercator Medical SA FRA:MM2
62 GF Score
Price €11.76
GF Value €10.65
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical Marketable Securities?

Mercator Medical FRA:MM2 +2.98% 62 Marketable Securities is €11.6 Mil as of Mar. 2026. GuruFocus rates FRA:MM2 with a GF Score™ of 62/100 and a GF Value™ of €10.65 (Fairly Valued). The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Mercator Medical's Marketable Securities for the quarter that ended in Mar. 2026 was €11.6 Mil.

Mercator Medical's annual Marketable Securities increased from Dec. 2023 (€25.0 Mil) to Dec. 2024 (€28.9 Mil) but then declined from Dec. 2024 (€28.9 Mil) to Dec. 2025 (€13.4 Mil).

Mercator Medical  (FRA:MM2) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Mercator Medical Marketable Securities Related Terms

Mercator Medical Marketable Securities Historical Data

* Premium members only.

The historical data trend for Mercator Medical's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical Marketable Securities Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.66 45.29 24.99 28.90 13.41

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.80 18.09 16.39 13.41 11.55
FRA:MM2
62GF Score
Mercator Medical SA FRA:MM2
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €11.6 Mil mean?
Mercator Medical (FRA:MM2) has a Marketable Securities of €11.6 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Mercator Medical and its competitors.
Is Mercator Medical's Marketable Securities too high?
Mercator Medical's current Marketable Securities is €11.6 Mil. Overall, Mercator Medical has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's Marketable Securities compare to ISRG and BDX?
Mercator Medical's Marketable Securities of €11.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Mercator Medical and its competitors. Mercator Medical's current Marketable Securities is €11.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €10.65, compared to a current price of €11.76 — trading 10.4% above its estimated fair value. The current Marketable Securities is €11.6 Mil. Mercator Medical's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current Marketable Securities is €11.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €11.76 is trading 10.4% above its estimated GF Value™ of €10.65. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for FRA:MM2:

  • Marketable Securities: €11.6 Mil
  • GF Value™: €10.65 vs. price of €11.76 (10.4% above fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
62GF Score

Get the complete analysis for FRA:MM2

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.76
Price
€10.65
GF Value